ALEMBIC PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of ALEMBIC PHARMACEUTICALS have increased by 6.54% YoY .
The Earnings Per Share (EPS) of ALEMBIC PHARMACEUTICALS has decreased by -34.34 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ALEMBIC PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 533573|NSE : APLLTD]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr | ₹3,935 Cr |
| Expenses | ₹4,945 Cr | ₹4,432 Cr | ₹3,913 Cr | ₹3,392 Cr | ₹3,079 Cr |
| Operating Profit (Excl OI) | ₹708 Cr | ₹874 Cr | ₹1,480 Cr | ₹1,214 Cr | ₹856 Cr |
| Other Income | ₹3.04 Cr | ₹50 Cr | ₹87 Cr | ₹14 Cr | ₹27 Cr |
| Interest | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr | ₹18 Cr |
| Depreciation | ₹275 Cr | ₹287 Cr | ₹183 Cr | ₹157 Cr | ₹115 Cr |
| Profit Before Tax | ₹355 Cr | ₹625 Cr | ₹1,368 Cr | ₹1,000 Cr | ₹749 Cr |
| Profit After Tax | ₹342 Cr | ₹521 Cr | ₹1,115 Cr | ₹801 Cr | ₹593 Cr |
| Consolidated Net Profit | ₹342 Cr | ₹521 Cr | ₹1,147 Cr | ₹829 Cr | ₹584 Cr |
| Earnings Per Share (Rs) | ₹17.40 | ₹26.50 | ₹58.33 | ₹43.97 | ₹31.00 |
| PAT Margin (%) | 6.05 | 9.82 | 20.67 | 17.38 | 15.06 |
| ROE(%) | 7.12 | 10.11 | 26.91 | 26.97 | 24.00 |
| ROCE(%) | 7.44 | 11.25 | 26.28 | 23.30 | 22.66 |
| Total Debt/Equity(x) | 0.15 | 0.12 | 0.10 | 0.54 | 0.42 |
Key Financials |
||
| Market Cap | : | ₹ 18,693.7 Cr |
| Revenue (TTM) | : | ₹ 6,118.1 Cr |
| Net Profit(TTM) | : | ₹ 599.3 Cr |
| EPS (TTM) | : | ₹ 30.5 |
| P/E (TTM) | : | 31.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC PHARMACEUTICALS | 3% | -8.2% | 93.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
ALEMBIC PHARMACEUTICALS Revenues
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 6.54 % |
| 5 Yr CAGR | 9.48 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹5,653 Cr | 6.54 | |
| Mar2022 | ₹5,306 Cr | -1.62 | |
| Mar2021 | ₹5,393 Cr | 17.10 | |
| Mar2020 | ₹4,606 Cr | 17.06 | |
| Mar2019 | ₹3,935 Cr | - | |
ALEMBIC PHARMACEUTICALS Operating Profit
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | -19.00 % |
| 5 Yr CAGR | -4.63 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹708 Cr | -19.00 | |
| Mar2022 | ₹874 Cr | -40.94 | |
| Mar2021 | ₹1,480 Cr | 21.91 | |
| Mar2020 | ₹1,214 Cr | 41.86 | |
| Mar2019 | ₹856 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -23.97 % |
| 5 Yr CAGR | -12.88 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 12.53% | -23.97 | |
| Mar2022 | 16.48% | -39.94 | |
| Mar2021 | 27.44% | 4.10 | |
| Mar2020 | 26.36% | 21.20 | |
| Mar2019 | 21.75% | - | |
ALEMBIC PHARMACEUTICALS Profit After Tax
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | -34.35 % |
| 5 Yr CAGR | -12.54 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹342 Cr | -34.35 | |
| Mar2022 | ₹521 Cr | -54.56 | |
| Mar2021 | ₹1,147 Cr | 38.33 | |
| Mar2020 | ₹829 Cr | 41.83 | |
| Mar2019 | ₹584 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -38.39 % |
| 5 Yr CAGR | -20.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 6.05 % | -38.39 | |
| Mar2022 | 9.82 % | -52.49 | |
| Mar2021 | 20.67 % | 18.93 | |
| Mar2020 | 17.38 % | 15.41 | |
| Mar2019 | 15.06 % | - | |
ALEMBIC PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | -34.34 % |
| 5 Yr CAGR | -13.44 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹17 | -34.34 | |
| Mar2022 | ₹27 | -54.57 | |
| Mar2021 | ₹58 | 32.66 | |
| Mar2020 | ₹44 | 41.84 | |
| Mar2019 | ₹31 | - | |
ALEMBIC PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | -33.87 % |
| 5 Yr CAGR | -24.30 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 7.44% | -33.87 | |
| Mar2022 | 11.25% | -57.19 | |
| Mar2021 | 26.28% | 12.79 | |
| Mar2020 | 23.3% | 2.82 | |
| Mar2019 | 22.66% | - | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹950.9 |
| Current MarketCap | : | ₹ 18,693.7 Cr |
| Updated EOD on | : | Apr 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 3% |
-8.2% |
93.9% |
| SENSEX | 1.3% |
2.6% |
24% |
ALEMBIC PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
| S&P BSE 250 SMALLCAP | 2.5% | 12.8% | 64.9% |
| S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
| S&P BSE 400 MIDSMALLCAP | 1.9% | 9.9% | 59.4% |
| S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 2.8% | 13.8% | 71.1% |
| NIFTY MID SMALL400 | 2.1% | 10.7% | 62.3% |
| NIFTY500 MULTICAP 50:25:25 | 1.8% | 7.7% | 48.1% |
| NIFTY 500 | 1.5% | 5.7% | 39.5% |
You may also like the below Video Courses
FAQ about ALEMBIC PHARMACEUTICALS Financials
How the annual revenues of ALEMBIC PHARMACEUTICALS have changed ?
The Revenues of ALEMBIC PHARMACEUTICALS have increased by 6.54% YoY .
How the Earnings per Share (EPS) of ALEMBIC PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of ALEMBIC PHARMACEUTICALS has decreased by -34.34 % YoY .
Check out Intrinsic Value of Peers of ALEMBIC PHARMACEUTICALS
Compare Stock Analytics of Peers of ALEMBIC PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
